Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
Proscovia B. Namujju(Tampere University), Matti Lehtinen(Karolinska Institutet)
Cited by 11
Related Papers
Scientific approaches toward improving cervical cancer elimination strategies
|International Journal of Cancer|2024|24
Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women
|International Journal of Cancer|2025|5
Elimination of cervical cancer by refined vaccination and screening
|International Journal of Cancer|2024|3